Year: 2022
Type: article
Abstract: Oral squamous cell carcinoma (OSCC) therapy is unsatisfactory, and the prevalence of the disease is increasing. The role of mitochondria in OSCC therapy has recently attracted increasing attention, however, many mechanisms remain unclear. Therefore, we elaborate upon relative studies in this review to achieve a better therapeutic effect of OSCC treatment in the future. Interestingly, we found that mitochondria not only contribute to OSCC therapy but also promote resistance, and targeting the mitochondria of OSCC via nanoparticles is a promising way to treat OSCC.
Source: Cancers
Authors: Junqiang Bai, Luping Wu, Xinmiao Wang, Yifan Wang, Zhengjun Shang, Erhui Jiang, Zhe Shao
Institution: Wuhan University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,513
Awards: G6390795342, G773220471
OpenAlex ID: W4309689950